Hypertrophic cardiomyopathy

@article{Maron2013HypertrophicC,
  title={Hypertrophic cardiomyopathy},
  author={B. Maron and M. Maron},
  journal={The Lancet},
  year={2013},
  volume={381},
  pages={242-255}
}
  • B. Maron, M. Maron
  • Published 2013
  • Medicine
  • The Lancet
  • Hypertrophic cardiomyopathy is a common inherited cardiovascular disease present in one in 500 of the general population. It is caused by more than 1400 mutations in 11 or more genes encoding proteins of the cardiac sarcomere. Although hypertrophic cardiomyopathy is the most frequent cause of sudden death in young people (including trained athletes), and can lead to functional disability from heart failure and stroke, the majority of affected individuals probably remain undiagnosed and many do… CONTINUE READING
    172 Citations

    Paper Mentions

    Interventional Clinical Trial
    Hypertrophic Cardiomyopathy (HCM) is the most common hereditary heart disease with high mortality. Heart failure is the most common complication (about 50% incidence) in these… Expand
    ConditionsFibrosis, Hypertrophic Cardiomyopathy
    InterventionDrug
    Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    • 395
    • PDF
    Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management
    • 6
    Hypertrophic cardiomyopathy in the developing world: focus on India.
    • 10
    • Highly Influenced
    • PDF
    Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function.
    • Y. Wada, T. Aiba, +17 authors H. Ogawa
    • Medicine
    • Circulation journal : official journal of the Japanese Circulation Society
    • 2015
    • 18
    • PDF
    Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    • 8
    • PDF
    Sudden cardiac death.
    • 23
    • Highly Influenced
    • PDF
    Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    • 157
    Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    • 17

    References

    SHOWING 1-10 OF 142 REFERENCES
    Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
    • 464
    • PDF
    Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
    • 351
    Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    • 481
    Determinants for clinical diagnosis of hypertrophic cardiomyopathy.
    • 51